Call for assistance with the referral process
Project TRUST’s goal is to help anyone who is actively struggling with substance use access comprehensive and compassionate care without judgement. We provide addiction treatment resources, harm reduction education and supplies, and navigation to an array of medical services including primary care and urgent care services. The Project TRUST team is made up of compassionate community health workers, who use their lived experience to guide people in active addiction. The Project TRUST drop-in was started in 1988 in response to the first wave of HIV in Boston among persons who use injection drugs. We have continued with our mission to provide comprehensive services that stop the transmission of infectious diseases in those who struggle with substance use.
Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report. - Harris M, Johnson S, Mackin S, Saitz R, Walley AY, Taylor JL. J Addict Med. 2020;14(4):e136-e138. doi:10.1097/ADM.0000000000000682
Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings : Harm Reduction in Outpatient Addiction Treatment - Taylor JL, Johnson S, Cruz R, Gray JR, Schiff D, Bagley SM. [published online ahead of print, 2021 Jun 22]. J Gen Intern Med. 2021;1-10. doi:10.1007/s11606-021-06904-4
Partnering With State Health Departments to Address Injection-Related Infections During the Opioid Epidemic: Experience at a Safety Net Hospital. - Burns RH, Pierre CM, Marathe JG, et al. Open Forum Infect Dis. 2021;8(8):ofab208. Published 2021 Apr 27. doi:10.1093/ofid/ofab208
Residency and Fellowship Information
Addiction Medicine Fellowship
The mission of the Grayken Fellowship in Addiction Medicine is to train physician addiction medicine leaders in clinical care, research, education, public health, and advocacy to improve addiction care for people vulnerable to health inequities due to race, ethnicity, gender, poverty, age, disability or stigmatizing illness.
The Grayken Addiction Medicine Fellowship Program is a 1 or 2 year fellowship. There is also a 3-year combined Infectious Disease-Addiction Medicine Fellowship and a 2-year Fellowship in Maternal Health Addiction. Fellows are mentored by our multidisciplinary faculty from Internal Medicine, Infectious Disease, Emergency Medicine, Obstetrics & Gynecology and Addiction Psychiatry. The Grayken Fellowship in Addiction Medicine is accredited by the ACGME. Click here to learn more
Latest from HealthCity
To better engage overdose survivors and remove barriers to treatment, research suggests that outreach programs consider limiting the practice.
The immune response known as ADCC is associated with protection against transmission of the virus, research from BMC shows.
Grayken Center for Addiction staff testified to the state on the need for safe consumption sites to address opioid overdose deaths.
HEALing Communities Study data underscores the need for racially inclusive approaches to address the opioid epidemic in vulnerable neighborhoods.
The HEALing Communities Study is up and running in several cities, bringing opioid use disorder treatment to people where they are.
To quell a rising epidemic, BMC has embedded HIV counselors in the ED to increase declining testing rates and connect people to effective treatment.
A study reveals that people at a drug detoxification site were unaware of HIV pre-exposure prophylaxis, or PrEP, but were enthusiastic when informed.
The HIV outbreak impacting people who inject drugs has only escalated during the pandemic — here's how it's being addressed.
A discussion with the medical director of the National Harm Reduction Coalition sheds light on structural failures that impact people with SUD.
'People's experience could be so much more humane,' expert says on the impact of policy and pandemic response on people at risk of drug-related harms.
Infectious disease physician will use NIDA grant to create a novel surveillance network for people who use drugs, emphasizing community engagement.
Isolation and barriers to harm reduction services could increase overdoses and new HIV infections among people who use drugs, experts worry.